Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages. (journals.asm.org)

Authors: Varik V … Van Bambeke F Journal: Antimicrobial Agents and Chemotherapy Published: 2026-01-07 DOI: https://doi.org/10.1128/aac.01319-25